It woudl be surprising if we do not hear about a dividend in this call. Seems like they should be able to announce one. Some leases will not be finalized per company until Q2. I woudl guess before end of Q2, company will have fully leased everything and can begin to shop the company.
exactly. if you look at the numbers they are almost at the ceiling with the current authorized so have to increase the authorized to allow for options and restricted share grants. it is routine at all public companies to always have a comfortable cushion
wit another PR tonight looking for a plaintiff. I guess they missed the new yesterday. They are as desperate as the shorts. What an embarrassment to my profession.
earth, mob isn't what it used to be/ Great article in NY Times about all the arrests of king pins now who are resorting to begging for mercy because of their age and their problems taking a leak, bladder issues etc.
Must be the comments from a certain analyst this morning who acknowledges the matter is closed but claims that his thesis has never been predicated on the OIG subpoena. He actually HIGHLIGHTS a paragraph from his last note which raised 4 key points. Guess what point #1 was? Yes, you guessed it right and get a prize! "1) On a macrol level there appear to be questionable sales practices in the field in general". So appparenlty his theses was significantly predicated on sales practices which has now been looked at by the OIG who essentially decided "no issues we see". To his credit he actually does say that he takes MiMedx at its word that it has implicitly been proven innocent based on all the documentation provided. Mighty big of him eh? He also babbles on that MDXG's strong political connections have been well advertised by the company on its conference calls (I didn't know he even bothered to listen in..I know they won't take his calls..so I hear anyway) and says the company continues to do well in marshalling its forces to grow its business. But in the end, shorty comes out and says his thesis is unchanged..concerns about sustainability of growth trajectory (of course, he said the same thing last year while the company continued to grow), interpretations of 361 regs and a changing reimbursement landscape which could dent expectations (a concern already disproven). His price target is still $7 and on the sidelines..of course, it's pretty clear he and his group are not on the sidelines but rather drowning in their shorts.
from Lakestreet "resolution of the request removes an overhang on this BUY rated stock, which should permit it to resume moving toward our $14 price target."
At this time, Candy is on his way to CVS to buy some KY Jelly for his reck-tum. remember, he shorted the stock at 5 because the chubby lady and the mob told hm to short it down to $3. Poor candy/cez/chubbyreporter/Suraj
And once again candy/cez keeps his perfect record alive of being wrong 100% of the time on MDXG since he bought into the bottom feed ambulance chaser lawfirms which slandered the company in their press releases claiming MDXG had engaged in illegal sales practices.
American Academy of Pain Medicine Annual meeting last week, a poster was presented by several doctors from the Department of Anesthesiology at the Naval Medical Center in San Diego. Several patients who had shoulder pain and MRI proven medial rotator cuff pathology and concordant pain were injected with AmnioFix. All cases had significant long term improvement post injection with AmnioFIx. See link below and attached poster. Cant link here but see stocktwits. Can click on view poster at link there.
And did OSIR break down where their revenue came from? I am guessing not, that they were their usual secretive self.
Not sure where you pulled this list from? I do not see the conferences this week tomorrow and Wednesday. I don't think the near future will be pleasant for shorts. Of course, it hasn't been pleasant for the shorts period here.
Considering the fact MiMedx outgrew its current space not much after the ink dried on the lease for the last expansion, and the representation that an additional 150 jobs will be created over the next two years (likely some Georgia incentives involved for the job creattion so the Company must expect to add those jobs). seems like only a fool (AKA Candy/Cez/Suraj/Chubby reporter) would short a company growing exponentially or be a "strong sell",
I put link on stock twits
MiMedx expanding in Marietta, adding up to 150 jobs
Mar 10, 2015, 2:11pm EDT
Ellie Hensley and Douglas Sams
Atlanta Business Chronicle
Marietta biotech company MiMedx Group is expanding, with plans to add up to 150 jobs over the next two years.
MidMedx (NASDAQ: MDXG) will build out additional space at 1828 West Oak Parkway, a group of low-rise office buildings near the company's existing headquarters, where it is at capacity.
MiMedx makes regenerative biomaterials and bioimplants, processed from human amniotic membrane, to care for wounds and heal burns. The products are also used in surgery and sports medicine.
MiMedx reported fourth quarter net income of $3.8 million on revenues of almost $40 million. In a recent call with analysts, MiMedx executives talked about expanding, especially in the segment of its products focused on wound care.
MiMedx is led by Chairman and CEO Pete Petit.
In the recent negotiations for the Marietta expansion, Greg Baxendale of Jones Lang LaSalle Inc. (JLL) and Doug Eidson of Avison Young represented MiMedx, which took another 25,600 square feet at 1828 West Oak Parkway to accommodate its growth.
As we have said. His predictions have been flawless. As long as his predictions were made on "opposite day".
Minor competitor. Since OSIR refuses to disclose where their revenue is from, who knows how much revenue is really revenue against product sold by MDXG. OSIR is very secretive.